Concepts (238)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
tau Proteins | 53 | 2024 | 2106 | 3.790 |
Why?
|
Amyloid beta-Peptides | 72 | 2024 | 3886 | 3.600 |
Why?
|
Alzheimer Disease | 79 | 2024 | 8717 | 3.190 |
Why?
|
Positron-Emission Tomography | 83 | 2024 | 6550 | 2.260 |
Why?
|
Aniline Compounds | 29 | 2024 | 1080 | 1.510 |
Why?
|
Aging | 24 | 2024 | 8729 | 1.440 |
Why?
|
Brain | 49 | 2024 | 27163 | 1.270 |
Why?
|
Thiazoles | 29 | 2024 | 1530 | 1.230 |
Why?
|
Carbolines | 15 | 2024 | 288 | 1.050 |
Why?
|
Presenilin-1 | 9 | 2024 | 665 | 0.940 |
Why?
|
Cerebral Cortex | 14 | 2024 | 5754 | 0.910 |
Why?
|
Amyloid | 13 | 2024 | 849 | 0.870 |
Why?
|
Nerve Net | 10 | 2024 | 2307 | 0.830 |
Why?
|
Magnetic Resonance Imaging | 67 | 2024 | 36582 | 0.720 |
Why?
|
Heterozygote | 7 | 2023 | 2794 | 0.710 |
Why?
|
Nanostructures | 2 | 2022 | 549 | 0.680 |
Why?
|
Locus Coeruleus | 5 | 2024 | 241 | 0.670 |
Why?
|
Temporal Lobe | 14 | 2024 | 1717 | 0.640 |
Why?
|
Cerebral Amyloid Angiopathy, Familial | 1 | 2019 | 53 | 0.640 |
Why?
|
Entorhinal Cortex | 9 | 2023 | 285 | 0.640 |
Why?
|
Ethylene Glycols | 3 | 2019 | 197 | 0.630 |
Why?
|
Atrophy | 11 | 2024 | 1631 | 0.630 |
Why?
|
Tauopathies | 5 | 2021 | 325 | 0.610 |
Why?
|
Aged, 80 and over | 67 | 2024 | 59548 | 0.580 |
Why?
|
Neural Pathways | 12 | 2024 | 3078 | 0.530 |
Why?
|
Aged | 103 | 2024 | 171319 | 0.530 |
Why?
|
Memory Disorders | 7 | 2024 | 1193 | 0.530 |
Why?
|
Radiopharmaceuticals | 6 | 2020 | 2702 | 0.510 |
Why?
|
Hippocampus | 12 | 2020 | 3777 | 0.480 |
Why?
|
Longitudinal Studies | 29 | 2024 | 14766 | 0.470 |
Why?
|
Brain Mapping | 14 | 2018 | 6597 | 0.460 |
Why?
|
Cerebrovascular Circulation | 1 | 2024 | 2672 | 0.440 |
Why?
|
Memory | 9 | 2020 | 2192 | 0.420 |
Why?
|
Peptide Fragments | 5 | 2019 | 5141 | 0.420 |
Why?
|
Cognition | 16 | 2024 | 7059 | 0.410 |
Why?
|
Amyloidosis | 5 | 2023 | 876 | 0.410 |
Why?
|
Male | 108 | 2024 | 364203 | 0.380 |
Why?
|
Mental Recall | 5 | 2020 | 1218 | 0.370 |
Why?
|
Image Processing, Computer-Assisted | 15 | 2021 | 8940 | 0.370 |
Why?
|
Apathy | 3 | 2019 | 107 | 0.370 |
Why?
|
Female | 110 | 2024 | 396660 | 0.360 |
Why?
|
Zebrafish | 1 | 2022 | 3036 | 0.350 |
Why?
|
Parietal Lobe | 3 | 2024 | 861 | 0.340 |
Why?
|
Cross-Sectional Studies | 32 | 2024 | 26325 | 0.340 |
Why?
|
Apolipoprotein E4 | 7 | 2020 | 709 | 0.330 |
Why?
|
Humans | 126 | 2024 | 767040 | 0.280 |
Why?
|
Aphasia, Primary Progressive | 2 | 2019 | 84 | 0.280 |
Why?
|
Models, Theoretical | 1 | 2018 | 3561 | 0.270 |
Why?
|
Parahippocampal Gyrus | 2 | 2020 | 117 | 0.270 |
Why?
|
Cerebral Amyloid Angiopathy | 3 | 2022 | 887 | 0.260 |
Why?
|
Phosphorus | 3 | 2022 | 336 | 0.260 |
Why?
|
Neuropsychological Tests | 18 | 2024 | 7121 | 0.260 |
Why?
|
Lewy Body Disease | 2 | 2019 | 254 | 0.250 |
Why?
|
Disease Progression | 14 | 2022 | 13646 | 0.250 |
Why?
|
Ecology | 1 | 2024 | 105 | 0.220 |
Why?
|
Models, Neurological | 4 | 2020 | 1747 | 0.210 |
Why?
|
Soil | 2 | 2021 | 119 | 0.200 |
Why?
|
Humic Substances | 1 | 2022 | 7 | 0.200 |
Why?
|
Fertilizers | 1 | 2022 | 24 | 0.200 |
Why?
|
Frontal Lobe | 3 | 2024 | 1408 | 0.200 |
Why?
|
Corpus Striatum | 2 | 2019 | 1217 | 0.200 |
Why?
|
Neurofibrillary Tangles | 2 | 2023 | 457 | 0.190 |
Why?
|
Middle Aged | 43 | 2024 | 223233 | 0.180 |
Why?
|
Basal Ganglia Diseases | 1 | 2021 | 145 | 0.180 |
Why?
|
Neocortex | 3 | 2024 | 414 | 0.180 |
Why?
|
Plaque, Amyloid | 2 | 2023 | 769 | 0.170 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2024 | 616 | 0.170 |
Why?
|
Cognition Disorders | 6 | 2018 | 3968 | 0.170 |
Why?
|
Apolipoprotein E3 | 1 | 2019 | 105 | 0.160 |
Why?
|
Soil Microbiology | 1 | 2019 | 92 | 0.160 |
Why?
|
Scopolamine | 1 | 2019 | 93 | 0.160 |
Why?
|
Fluorodeoxyglucose F18 | 6 | 2018 | 2028 | 0.160 |
Why?
|
Activities of Daily Living | 4 | 2023 | 2429 | 0.160 |
Why?
|
Cholinergic Antagonists | 1 | 2019 | 166 | 0.150 |
Why?
|
Durapatite | 1 | 2019 | 167 | 0.150 |
Why?
|
Agriculture | 1 | 2019 | 186 | 0.150 |
Why?
|
Apolipoproteins E | 3 | 2019 | 1459 | 0.150 |
Why?
|
Judgment | 1 | 2020 | 270 | 0.150 |
Why?
|
Amyloidogenic Proteins | 3 | 2023 | 151 | 0.140 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 1 | 2019 | 409 | 0.140 |
Why?
|
Nerve Degeneration | 1 | 2020 | 748 | 0.130 |
Why?
|
Loneliness | 1 | 2018 | 211 | 0.130 |
Why?
|
Linear Models | 8 | 2019 | 5875 | 0.130 |
Why?
|
Sex Characteristics | 3 | 2023 | 2647 | 0.120 |
Why?
|
Immunoassay | 1 | 2018 | 744 | 0.120 |
Why?
|
Choroid Plexus | 1 | 2018 | 249 | 0.120 |
Why?
|
Nonlinear Dynamics | 1 | 2016 | 490 | 0.110 |
Why?
|
Longevity | 1 | 2022 | 1083 | 0.110 |
Why?
|
Parkinson Disease | 2 | 2019 | 2886 | 0.110 |
Why?
|
Presenilin-2 | 1 | 2013 | 100 | 0.110 |
Why?
|
Pattern Recognition, Visual | 1 | 2019 | 820 | 0.110 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2024 | 3511 | 0.110 |
Why?
|
Gyrus Cinguli | 2 | 2018 | 1118 | 0.100 |
Why?
|
Olfaction Disorders | 1 | 2015 | 225 | 0.100 |
Why?
|
Visual Pathways | 1 | 2016 | 554 | 0.100 |
Why?
|
Cohort Studies | 10 | 2024 | 41718 | 0.100 |
Why?
|
Cues | 1 | 2017 | 877 | 0.100 |
Why?
|
Caenorhabditis elegans | 1 | 2021 | 1474 | 0.100 |
Why?
|
Semantics | 1 | 2015 | 609 | 0.100 |
Why?
|
Mental Status Schedule | 3 | 2017 | 315 | 0.100 |
Why?
|
Cerebrovascular Disorders | 1 | 2018 | 1478 | 0.090 |
Why?
|
Adult | 21 | 2024 | 223317 | 0.090 |
Why?
|
Intelligence | 1 | 2016 | 925 | 0.090 |
Why?
|
Neurodegenerative Diseases | 1 | 2019 | 1089 | 0.090 |
Why?
|
Body Mass Index | 2 | 2020 | 13048 | 0.090 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2013 | 279 | 0.080 |
Why?
|
Alleles | 2 | 2019 | 6893 | 0.080 |
Why?
|
Adaptation, Physiological | 1 | 2016 | 1312 | 0.080 |
Why?
|
Visual Cortex | 1 | 2016 | 1081 | 0.080 |
Why?
|
Colombia | 2 | 2021 | 287 | 0.080 |
Why?
|
Psychiatric Status Rating Scales | 5 | 2017 | 6023 | 0.080 |
Why?
|
Bacteria | 1 | 2019 | 2212 | 0.080 |
Why?
|
Mood Disorders | 1 | 2015 | 1129 | 0.070 |
Why?
|
Age Factors | 5 | 2018 | 18401 | 0.070 |
Why?
|
Nerve Tissue Proteins | 2 | 2023 | 4401 | 0.070 |
Why?
|
Nanoparticles | 1 | 2019 | 1966 | 0.070 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2013 | 1117 | 0.070 |
Why?
|
Follow-Up Studies | 6 | 2020 | 39317 | 0.070 |
Why?
|
Seizures | 1 | 2020 | 2996 | 0.070 |
Why?
|
Information Dissemination | 1 | 2015 | 1142 | 0.070 |
Why?
|
Homeodomain Proteins | 1 | 2016 | 2429 | 0.070 |
Why?
|
Organ Size | 3 | 2017 | 2264 | 0.070 |
Why?
|
Case-Control Studies | 3 | 2019 | 22254 | 0.060 |
Why?
|
Depression | 2 | 2017 | 8234 | 0.060 |
Why?
|
Biomedical Research | 1 | 2021 | 3464 | 0.060 |
Why?
|
Motor Activity | 1 | 2015 | 2713 | 0.060 |
Why?
|
Epilepsy | 1 | 2020 | 3317 | 0.060 |
Why?
|
Regression Analysis | 1 | 2014 | 6331 | 0.060 |
Why?
|
Cardiovascular Diseases | 2 | 2022 | 15645 | 0.060 |
Why?
|
Asymptomatic Diseases | 2 | 2019 | 588 | 0.060 |
Why?
|
Prefrontal Cortex | 1 | 2015 | 2224 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 4 | 2020 | 18063 | 0.060 |
Why?
|
Mutation | 5 | 2023 | 30211 | 0.060 |
Why?
|
Psychomotor Performance | 3 | 2018 | 1886 | 0.060 |
Why?
|
Nervous System Diseases | 1 | 2014 | 1660 | 0.060 |
Why?
|
Geriatric Assessment | 3 | 2016 | 1422 | 0.060 |
Why?
|
Animals, Wild | 1 | 2024 | 78 | 0.060 |
Why?
|
Fluorine Radioisotopes | 2 | 2017 | 405 | 0.060 |
Why?
|
Cognitive Reserve | 1 | 2024 | 92 | 0.050 |
Why?
|
Benzothiazoles | 2 | 2017 | 244 | 0.050 |
Why?
|
Life Style | 1 | 2015 | 3931 | 0.050 |
Why?
|
Age of Onset | 2 | 2024 | 3344 | 0.050 |
Why?
|
Risk | 3 | 2020 | 9606 | 0.050 |
Why?
|
Animals | 7 | 2024 | 168965 | 0.050 |
Why?
|
Executive Function | 3 | 2017 | 1396 | 0.050 |
Why?
|
Oxygen | 4 | 2016 | 4252 | 0.050 |
Why?
|
Contrast Media | 3 | 2019 | 5329 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2014 | 4052 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2020 | 20741 | 0.040 |
Why?
|
Gluconates | 1 | 2019 | 31 | 0.040 |
Why?
|
Young Adult | 6 | 2020 | 59980 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2016 | 20169 | 0.040 |
Why?
|
Spectroscopy, Fourier Transform Infrared | 1 | 2019 | 157 | 0.040 |
Why?
|
Apolipoprotein E2 | 1 | 2019 | 134 | 0.040 |
Why?
|
Hormones | 1 | 2023 | 865 | 0.040 |
Why?
|
Static Electricity | 1 | 2019 | 258 | 0.040 |
Why?
|
X-Ray Diffraction | 1 | 2019 | 416 | 0.040 |
Why?
|
Adolescent | 6 | 2022 | 89046 | 0.040 |
Why?
|
Interleukin-12 | 1 | 2021 | 577 | 0.040 |
Why?
|
Occipital Lobe | 1 | 2020 | 376 | 0.040 |
Why?
|
Australia | 1 | 2022 | 1263 | 0.040 |
Why?
|
Hydrodynamics | 1 | 2019 | 164 | 0.040 |
Why?
|
Retrospective Studies | 4 | 2020 | 81659 | 0.040 |
Why?
|
Risk Factors | 6 | 2024 | 74886 | 0.040 |
Why?
|
Phenanthrolines | 1 | 2017 | 48 | 0.040 |
Why?
|
Cerebral Hemorrhage | 2 | 2022 | 2655 | 0.040 |
Why?
|
Self Report | 2 | 2019 | 3773 | 0.040 |
Why?
|
Names | 1 | 2017 | 54 | 0.040 |
Why?
|
Thiones | 1 | 2017 | 50 | 0.040 |
Why?
|
Functional Laterality | 2 | 2014 | 2245 | 0.030 |
Why?
|
Palmitates | 1 | 2017 | 68 | 0.030 |
Why?
|
Extracellular Space | 1 | 2018 | 563 | 0.030 |
Why?
|
Prospective Studies | 4 | 2023 | 54886 | 0.030 |
Why?
|
Behavior, Animal | 1 | 2024 | 1865 | 0.030 |
Why?
|
Diagnostic Self Evaluation | 1 | 2017 | 228 | 0.030 |
Why?
|
Body Height | 1 | 2022 | 1565 | 0.030 |
Why?
|
Phosphorylation | 2 | 2017 | 8310 | 0.030 |
Why?
|
Autopsy | 1 | 2019 | 1011 | 0.030 |
Why?
|
Particle Size | 1 | 2019 | 1633 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2014 | 6215 | 0.030 |
Why?
|
Menopause | 1 | 2023 | 1655 | 0.030 |
Why?
|
Neoplasms | 1 | 2024 | 22350 | 0.030 |
Why?
|
Homozygote | 1 | 2019 | 1774 | 0.030 |
Why?
|
Sex Factors | 2 | 2019 | 10622 | 0.030 |
Why?
|
Severity of Illness Index | 3 | 2018 | 15925 | 0.030 |
Why?
|
Melanocytes | 1 | 2018 | 509 | 0.030 |
Why?
|
Tongue | 1 | 2017 | 406 | 0.030 |
Why?
|
Diffusion Tensor Imaging | 2 | 2015 | 2421 | 0.030 |
Why?
|
Cocaine | 1 | 2019 | 944 | 0.030 |
Why?
|
Memory, Short-Term | 1 | 2020 | 1004 | 0.030 |
Why?
|
Attention | 1 | 2024 | 2413 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 1 | 2019 | 1969 | 0.030 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2012 | 139 | 0.030 |
Why?
|
Verbal Learning | 1 | 2014 | 459 | 0.030 |
Why?
|
Prognosis | 3 | 2017 | 29963 | 0.020 |
Why?
|
Pedigree | 1 | 2019 | 4539 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2015 | 950 | 0.020 |
Why?
|
Forecasting | 1 | 2020 | 2936 | 0.020 |
Why?
|
Independent Living | 1 | 2016 | 584 | 0.020 |
Why?
|
Face | 1 | 2017 | 1029 | 0.020 |
Why?
|
Anisotropy | 1 | 2014 | 1289 | 0.020 |
Why?
|
Genes, Dominant | 1 | 2013 | 855 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2850 | 0.020 |
Why?
|
Learning | 1 | 2020 | 1754 | 0.020 |
Why?
|
Parents | 1 | 2024 | 3594 | 0.020 |
Why?
|
Photic Stimulation | 1 | 2016 | 1989 | 0.020 |
Why?
|
Hemorrhage | 1 | 2022 | 3464 | 0.020 |
Why?
|
Acoustic Stimulation | 1 | 2014 | 1253 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2014 | 1987 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2012 | 1002 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2024 | 12451 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3431 | 0.020 |
Why?
|
Escherichia coli | 1 | 2021 | 4209 | 0.020 |
Why?
|
Task Performance and Analysis | 1 | 2013 | 771 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2016 | 1458 | 0.020 |
Why?
|
Algorithms | 2 | 2021 | 14098 | 0.020 |
Why?
|
Rest | 1 | 2013 | 941 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9360 | 0.020 |
Why?
|
Internationality | 1 | 2013 | 1006 | 0.020 |
Why?
|
Brain Concussion | 1 | 2018 | 1431 | 0.020 |
Why?
|
Software | 1 | 2021 | 4472 | 0.020 |
Why?
|
Calcium | 1 | 2019 | 5792 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2018 | 3370 | 0.020 |
Why?
|
Electroencephalography | 1 | 2020 | 6282 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2015 | 2116 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2011 | 2350 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 14672 | 0.010 |
Why?
|
Pilot Projects | 1 | 2017 | 8732 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12986 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 12536 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2016 | 12793 | 0.010 |
Why?
|
Signal Transduction | 1 | 2023 | 23621 | 0.010 |
Why?
|
Genotype | 1 | 2014 | 13035 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 16036 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 24299 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15851 | 0.010 |
Why?
|
Mice | 1 | 2023 | 81912 | 0.010 |
Why?
|
Child | 1 | 2015 | 80771 | 0.000 |
Why?
|
Concepts
(238)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(90)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_